Identification of Candidate Predictive and Surrogate Molecular Markers for Dasatinib in Prostate Cancer: Rationale for Patient Selection and Efficacy Monitoring

Genome Biology
doi 10.1186/gb-2007-8-11-r255
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Prostate-Specific Antigen, Its Molecular Forms, and Other Kallikrein Markers for Detection of Prostate Cancer

Urology
Urology
2002English

Molecular Prognostic and Predictive Markers in Colorectal Cancer: Current Status

Current Colorectal Cancer Reports
HepatologyOncologyGastroenterology
2011English

Abiraterone Acetate for Early Stage Metastatic Prostate Cancer: Patient Selection and Special Considerations

Therapeutics and Clinical Risk Management
2018English

Markers for Diagnosis and Monitoring of Human Cancer

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1982English

High-Dose-Rate Brachytherapy Boost for Prostate Cancer: Rationale and Technique

Journal of Contemporary Brachytherapy
Nuclear MedicineRadiologyImagingOncology
2014English

Immune Monitoring Technology Primer: Clinical Validation for Predictive Markers

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Management Strategies and Patient Selection After a Hospital Funding Reform for Prostate Cancer Surgery in Canada

JAMA network open
Medicine
2019English

Surrogate Markers for Cardiovascular Disease: Structural Markers

Circulation
Cardiovascular MedicinePhysiologyCardiology
2004English

Identification of Stem-Like Cells and Clinical Significance of Candidate Stem Cell Markers in Gastric Cancer

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy